WO2016167002A1 - Medical tubular body - Google Patents

Medical tubular body Download PDF

Info

Publication number
WO2016167002A1
WO2016167002A1 PCT/JP2016/051924 JP2016051924W WO2016167002A1 WO 2016167002 A1 WO2016167002 A1 WO 2016167002A1 JP 2016051924 W JP2016051924 W JP 2016051924W WO 2016167002 A1 WO2016167002 A1 WO 2016167002A1
Authority
WO
WIPO (PCT)
Prior art keywords
tubular body
medical tubular
ring
body according
annular
Prior art date
Application number
PCT/JP2016/051924
Other languages
French (fr)
Japanese (ja)
Inventor
学 西尾
Original Assignee
株式会社カネカ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社カネカ filed Critical 株式会社カネカ
Priority to JP2017512209A priority Critical patent/JPWO2016167002A1/en
Publication of WO2016167002A1 publication Critical patent/WO2016167002A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
    • A61F2/93Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section circumferentially expandable by using ratcheting locks

Definitions

  • the present invention relates to a medical tubular body that can be expanded in diameter, and is used, for example, to treat a lesion where a blood vessel or other in-vivo lumen is narrowed or occluded. More specifically, the present invention relates to a medical tubular body typified by a stent placed in a lesioned part of a living body lumen, or a medical tubular body used for removing a thrombus generated in a lesioned part.
  • a medical tubular body typified by a stent is generally a medical instrument for treating various diseases caused by stenosis or occlusion of a blood vessel or other living body lumen.
  • the medical tubular body has a lumen in the lesion such as a stenosis or occlusion that is expanded from the inside and is placed in the lesion to maintain the inner diameter of the lumen, or has occurred in or around the lesion. Examples include entanglement of a thrombus and the like to remove it from the body and recover the lumen inner diameter at the lesion.
  • FIG. 10 is a perspective view showing the configuration of a conventional annular body 100 of a stent. As shown in FIG. 10, the ring-shaped body 100 has a narrow portion 101 on one end side, and the narrow portion 101 is led out from the inside to the outside through a hole 102 provided in a part of the ring-shaped body 100. Has been.
  • Patent Document 1 a plurality of T-shaped unit portions including a head portion and an elongated body portion extending from the head portion are arranged side by side and are connected to each other at the head portion.
  • a polymer stent that is integrally formed is described.
  • each body portion is rounded and inserted into and locked in a slit formed in the head portion to form a ring shape, which becomes a tubular shape as a whole.
  • Patent Document 2 describes a stent that has a plurality of ring-shaped component pieces, and each ring-shaped component piece is connected to each other with a connecting piece at a necessary interval.
  • each ring component piece is provided on one end side, and the other end side is provided on the other end side.
  • the locking part that is passed to the outer surface side, the locking part side is passed through the insertion port so that the ring component piece becomes a ring shape, and the locking part is penetrated from the curved outer surface side to the inner surface side so that the locking part is
  • the locking position is provided with a plurality of locking receiving portions that move only in one direction in which the diameter of the ring component piece expands.
  • a part (the narrow portion 101 or the like) of the stent passes through the hole 102 provided in a part of the annular body 100. Since the structure protrudes outward, local stimulation is applied to the inner wall of the blood vessel, which may cause restenosis in the blood vessel.
  • a ridge-like protrusion is formed on the outer surface that comes into contact with a blood vessel, whereby stimulation is applied to the inner wall of the blood vessel, thereby causing restenosis.
  • a protrusion is formed in a ring-shaped portion passing through the insertion opening, which may cause restenosis.
  • An object of the present invention is to provide a medical tubular body that has a structure capable of expanding its diameter and has little irritation to an inner wall of a blood vessel or the like.
  • the medical tubular body of the present invention that has solved the above-described problems is a medical tubular body having a ring-shaped body that can be expanded in diameter, and the ring-shaped body has a circumferential direction and an axial direction. It has the 1st member currently formed in the partial area, and the 2nd member formed in the partial area of the circumferential direction, The said 1st member and the said 2nd member slide mutually in the circumferential direction Engageable.
  • the ring-shaped body 100 has a configuration capable of expanding the diameter
  • the portion protruding outward from the ring-shaped body 100 is smaller than the conventional ring-shaped body 100 (FIG. 10) described above. There is little irritation to the inner wall of the lumen in the living body.
  • the first member and the second member are slidable in a direction in which the circumference of the annular body increases, and are mutually in a direction in which the circumference of the annular body decreases. It is desirable not to slide.
  • a convex portion is formed on a surface of the first member that faces the second member, and a concave portion is formed on the surface of the second member that faces the first member. It is desirable that at least one of the convex part or the concave part has an anisotropic shape in the circumferential direction.
  • radiopaque markers are formed on the first member and the second member.
  • the first member and the second member each include a stopper portion that contacts each other.
  • the medical tubular body has a plurality of the annular bodies.
  • the plurality of annular bodies have different masses.
  • the plurality of ring-shaped bodies are connected to each other through a support column.
  • each support column is provided with a radiopaque marker, and the positions of the markers in the axial direction are different from each other.
  • the annular body is meandering, and the width of the meandering is preferably reduced as the diameter of the annular body increases.
  • the first member and the second member are not affected even when a stress is applied from the radially inner side to the outer side of the annular body. It is desirable to have a sliding drag that does not slide in the circumferential direction.
  • a width of the first member and a width of the second member in the axial direction of the annular body are different from each other.
  • the annular body contains a biodegradable substance.
  • the medical tubular body of the present invention includes a ring-shaped body having a first member formed in a partial section in the circumferential direction and a second member formed in a partial section in the circumferential direction. And the second member are slidably engaged with each other in the circumferential direction, so that there are few members projecting outward from the ring-shaped body while having a configuration capable of expanding the diameter, so that the inner wall of a blood vessel or the like There is little irritation.
  • the present invention can provide a medical tubular body that can reduce the probability of restenosis of a living body lumen.
  • FIG. 1 is a perspective view of a ring-shaped body of a medical tubular body according to a first embodiment of the present invention.
  • FIG. 2 is an enlarged exploded view of a portion A of the ring-shaped body of FIG.
  • FIG. 3 is an enlarged view of a portion A of the ring-shaped body of FIG. 1 and shows a state where the first member and the second member are engaged.
  • FIG. 4 is a diagram illustrating a state in which the first member and the second member of the annular body in FIG. 3 slide with each other.
  • FIG. 5 is a perspective view of the first member and the second member of the ring-shaped body of FIG. 4 as viewed from the B direction.
  • FIG. 6 is a perspective view of the medical tubular body according to the first embodiment of the present invention.
  • FIG. 7 is a development view of the medical tubular body according to the second embodiment of the present invention.
  • FIG. 8 is a perspective view of the medical tubular body according to the third embodiment of the present invention.
  • FIG. 9 is a perspective view of a medical tubular body according to the fourth embodiment of the present invention.
  • FIG. 10 is a perspective view of a conventional ring-shaped body.
  • tubular body Before describing in detail the medical tubular body according to the embodiment of the present invention, the general configuration of the medical tubular body will be described.
  • a configuration in which a marker made of a radiopaque material is removed from a medical tubular body is referred to as a “tubular body”.
  • the tubular body includes one or a plurality of ring-shaped bodies.
  • the medical tubular body is used in a living body lumen. For example, it is placed in a lesioned part of a living body lumen to maintain or expand the diameter of the living body lumen.
  • a thrombectomy device for removing a thrombus formed in a lumen in a living body or a peripheral protection device (peripheral protection filter).
  • the medical tubular body is used by being attached to a catheter (delivery system: delivery device) or the like having a portion where the medical tubular body is placed for delivery (delivery) to a lesioned part.
  • the classification from the viewpoint of the expansion mechanism of the medical tubular body includes (i) mounting (mounting) the medical tubular body on the outer surface of the balloon and transporting it to the lesioned area, It can be divided into a balloon expandable type that expands and a self-expandable type that expands by itself by removing the member that suppresses expansion at the lesioned part by transporting it to the lesioned part with a catheter having a member that suppresses expansion.
  • the medical tubular body contracts in the direction perpendicular to the longitudinal axis of the tubular body (the radial direction of the tube) and extends in the longitudinal axis direction. By this, it becomes a cylindrical shape (reduced diameter state) which is longer than the expanded state.
  • the diameter of the reduced diameter state can be reduced as compared with the balloon expansion type.
  • the tubular body is composed of, for example, a group of ring-shaped bodies, and the ring-shaped body is a structure that can be expanded in diameter and has a structure that extends the circumference of a band-shaped member.
  • “expandable diameter” means that the tube can be extended in a direction (radial direction) perpendicular to the long axis of the tubular body.
  • the tubular body may be contracted (reduced diameter) in reverse from the state in which the diameter is expanded, or may have a ratchet mechanism so that the diameter can be increased but not reduced.
  • the tubular body is formed, for example, from a pattern of interconnected structural elements that expand and contract in the circumferential and axial directions.
  • the tubular body in the present invention can be applied in any pattern and is therefore not limited to any particular stent shape or structural element pattern.
  • a marker including a radiopaque material is provided at a predetermined position of the medical tubular body so that the medical tubular body can be observed under fluoroscopy.
  • the marker does not need to completely block X-rays, and may be any X-ray transmittance that can detect the presence of the marker under fluoroscopy.
  • FIG. 1 is a perspective view of a ring-shaped body of a medical tubular body according to the first embodiment of the present invention.
  • a ring-shaped body 100 has a circumferential direction and an axial direction, and a first member 1 formed in a partial section in the circumferential direction and a second member 2 formed in a partial section in the circumferential direction. And have.
  • the partial section in the circumferential direction in which the first member 1 is formed has the meaning of excluding the entire circumference in the circumferential direction, but the place in the circumferential direction is not limited.
  • the second member 2 is also formed in a partial section in the circumferential direction, but the first member 1 and the second member 2 may be engaged with each other. It is not limited whether the two members 2 are formed in the same section as the first member 1 or are formed in a section different from the first member 1.
  • first member 1 and the second member 2 formed in this way are slid in the direction in which the overlapping portions of the first member 1 and the second member 2 decrease, the circumference of the annular body 100 increases, and as a result, the annular body 100 is expanded in diameter.
  • the medical tubular body according to the first embodiment of the present invention has a configuration in which the first member 1 and the second member 2 slide, so that the configuration shown in FIG. Compared to the case, there are few portions projecting outward from the ring-shaped body 100, and therefore there is less stimulation to the inner wall of the body lumen such as blood vessels. Therefore, the probability that the in-vivo lumen is restenosis can be reduced.
  • the shape of the annular body 100 in the present invention is most typically a circular shape, but is not limited to a circular shape, and includes an elliptical shape and a rectangular frame shape. Sa) is not limited.
  • the medical tubular body according to the present embodiment has the gist that the circumference of the annular body can be extended by sliding the first member 1 and the second member 2 engaged with each other as described above
  • it may further include a third member (not shown) formed in a partial section in the circumferential direction and overlapping the second member 2 in the circumferential direction.
  • the second member 2 and the third member may be slidably engaged with each other in the circumferential direction, or the second member 2 and the third member may be fixed to each other without sliding. .
  • the ring-shaped body 100 includes a plurality of first members 1 and a plurality of second members 2, and the first members 1 and the second members 2 are alternately arranged in the circumferential direction and in the axial direction. You may form by engaging alternately.
  • the ring-shaped body 100 is formed in a narrow range in the axial direction, so that the shape of the ring-shaped body 100 is not easily distorted.
  • first member 1 and the second member 2 are not particularly limited. Although details will be described later, for example, the first member 1 or the second member 2 may be provided with guide rails or grooves. The first member 1 and the second member 2 may be in line contact with each other in order to improve slippage, or may be in surface contact with each other in order to make slippage difficult.
  • the medical tubular body according to the present embodiment can preferably further include the following configuration.
  • the first member 1 and the second member 2 are configured to be slidable in the direction in which the circumference of the ring-shaped body 100 increases (that is, the diameter-enlarging direction of the ring-shaped body 100). It is also possible to adopt a configuration in which they do not slide with respect to each other in the direction in which the circumferential length decreases (that is, the diameter reduction direction of the annular body 100).
  • the ring-shaped body 100 with a ratchet mechanism, it is possible to cause the medical tubular body to perform a stepwise and irreversible diameter expansion operation. That is, when the balloon disposed inside the medical tubular body is inflated, the diameter of the medical tubular body is expanded, but the medical tubular body is not reduced in diameter even if the stress by the balloon is removed. The state can be maintained.
  • the ratchet mechanism for the ring-shaped body 100 for example, by giving a constant static friction resistance between the first member 1 and the second member 2, similarly, the stress from the inside caused by the balloon Even if there is not, the medical tubular body is not reduced in diameter by static friction, and the expanded diameter can be maintained.
  • FIG. 2 is an enlarged exploded view of part A of the ring-shaped body of FIG.
  • the first member 1 is formed with a convex portion 3 on the surface facing the second member 2
  • the second member 2 has the first member 1 with the first member 1.
  • a concave portion 4 is formed on the opposing surface, and the positional relationship between the first member 1 and the second member 2 is fixed by fitting the convex portion 3 and the concave portion 4 together.
  • at least one of the convex part 3 or the recessed part 4 has an anisotropic shape in the circumferential direction of the ring-shaped body 100, it is easy to slide in one direction of the circumferential direction, but difficult to slide in the other direction.
  • the concave portion 4 may be formed on the first member 1 and the convex portion 3 may be formed on the second member 2.
  • the third member is used as described above, the second member 2 is engaged with the first member 1 and is engaged with the third member. 2, the convex portion 3 or the concave portion 4 may be formed on the side facing the first member 1, and the convex portion 3 or the concave portion 4 may be formed on the side facing the third member.
  • first member 1 and the second member 2 In order for the first member 1 and the second member 2 to slide smoothly, it is preferable to use an elastic material such as a resin as the material of the first member 1 and the second member 2. If the 1st member 1 and the 2nd member 2 are comprised with the resin material, since the convex part 3 will fall easily in the direction where stress is applied, it will become easy to slide the 1st member 1 and the 2nd member 2. FIG.
  • the material used for the first member 1 and the second member 2 is not particularly limited as long as it is a material that can withstand a strong load at the time of deformation or indwelling, such as expansion or contraction.
  • 316L stainless steel, tantalum, Co—Cr (cobalt chromium) alloy, Ni—Ti (nickel-titanium) alloy, etc. which are medical stainless steels, can be preferably used.
  • a nickel-titanium alloy can be preferably used because it has elastic characteristics and is excellent in workability.
  • an alloy containing about 50% by mass to about 60% by mass of nickel can be preferably used.
  • the first member 1 and the second member 2 are viable when taking into account the deformation of blood vessels after surgery and patients with metal allergies.
  • a degradable material such as a biodegradable polymer or metal.
  • the biodegradable material may be a composite of at least two biodegradable polymers and / or metals. Examples of materials that can be used as biodegradable substances include polylactic acid, polycaprolactone, polyhydroxybutyrate, polyglycolic acid, silk elastin polymer, polyhydroxy acid copolymer, polyester, polysaccharide, and one of these. The composition containing the above is mentioned.
  • a plurality of convex portions 3 are provided for one first member 1.
  • a plurality of recesses 4 are provided for one second member 2.
  • the number of the convex portions 3 and the number of the concave portions 4 are not particularly limited, but the first member 1 and the second member 2 can be reduced by reducing the number of the convex portions 3 that are likely to have an acute angle structure to be smaller than the number of the concave portions 4.
  • the convex part 3 is exposed in the section which is not engaged, and the state which can contact
  • the convex portion 3 is not disposed over the entire length direction of the first member 1 (the circumferential direction of the ring-shaped body 100), but is provided only in a partial section in the length direction of the first member 1. Even in such a configuration, it is possible to avoid a state in which the convex portion 3 is exposed and can come into contact with the inner wall of the living body lumen.
  • the convex portion 3 is unevenly distributed inward in the radial direction of the first member 1.
  • the outer side of the first member 1 in the radial direction is a portion that can come into contact with the inner wall of the in-vivo lumen, in order to reduce the influence of the complicated shape of the convex portion 3 on the in-vivo lumen.
  • the recess 4 is unevenly distributed inward in the radial direction of the second member 2.
  • the outer side of the second member 2 in the radial direction is also a portion that can come into contact with the in-vivo lumen, in order to reduce the influence of the complicated shape of the recess 4 on the inner wall of the in-vivo lumen.
  • the first member 1 includes an upper stage 1 a that is in the axial direction (one side) of the annular body 100 and in the radial direction (inward) of the annular body 100, and the axial direction (other side) of the annular body 100. And the lower stage 1b in the radial direction (outward) of the ring-shaped body 100, and the convex part 3 on the upper stage 1a.
  • the second member 2 includes a lower stage 2 b in the axial direction (one side) of the annular body 100 and in the radial direction (inward) of the annular body 100, and the axial direction (other side) of the annular body 100.
  • the convex portion 3 is formed inside the first member 1 and is not exposed outwardly or inwardly in the radial direction of the first member 1.
  • the concave portion 4 is formed inside the second member 2, and is not exposed outwardly or inwardly in the radial direction of the second member 2.
  • a groove 5 extending in the circumferential direction of the ring-shaped body 100, that is, in the circumferential direction of the first member 1 is formed in the first member 1, while the groove 5 is formed in the second member 2.
  • a protrusion-shaped guide portion 6 is formed to be fitted to.
  • the first member 1 and the second member 2 are positioned so as not to be separated from each other by the fitting between the groove 5 and the guide portion 6. It is desirable that the guide portion 6 protrudes in a direction orthogonal to the protrusion direction of the convex portion 3. For example, as shown in FIG.
  • the guide portion 6 when the protruding direction of the convex portion 3 is the axial direction of the annular body 100, the guide portion 6 is preferably protruded in the radial direction of the annular body 100.
  • a fitting direction of the convex portion 3 and the concave portion 4 (axial direction of the annular body 100) and a fitting direction of the groove 5 and the guide portion 6 (radial direction of the annular body 100) are different.
  • the guide part 6 may extend in the circumferential direction of the second member 2 or may be provided only in a partial section of the second member 2.
  • FIG. 3 is an enlarged view of a portion A of the ring-shaped body of FIG. 1 and shows a state in which the first member 1 and the second member 2 are engaged.
  • FIG. 4 is a diagram illustrating a state in which the first member 1 and the second member 2 of the annular body in FIG. 3 slide with each other.
  • the convex portion 3 and the concave portion 4 preferably have an anisotropic shape in the circumferential direction. In this case, the first member 1 and the second member 2 slide in one direction. Easy, but difficult to slide in the reverse direction or cannot slide. For example, as shown in FIGS.
  • the convex portion 3 is inclined to one side in the circumferential direction, and the protrusion tip portion of the convex portion 3 is shifted to one side in the circumferential direction from the base portion of the convex portion 3. In position. Therefore, although the 1st member 1 is easy to slide to the other direction of the circumferential direction, it is hard to slide to the opposite one direction of the circumferential direction.
  • the convex part 3 is not inclined, it is desirable that the concave part 4 is inclined. Specifically, as shown in FIGS. 2 to 4, the bottom of the recess 4 (the location corresponding to the protrusion tip of the projection 3) is the opening of the recess 4 (the location corresponding to the base of the projection 3). Rather than one side in the circumferential direction.
  • both the convex part 3 and the recessed part 4 have an anisotropic shape in the circumferential direction.
  • a radiopaque marker 7 is formed on the first member 1 and the second member 2.
  • the degree of diameter expansion of the annular body 100 cannot be quantitatively confirmed. Therefore, by forming a radiopaque marker 7 at a predetermined position of the first member 1 and the second member 2, the first member 1 and the second member 2 can be obtained from the relative positional relationship of the markers 7.
  • the amount of diameter expansion of the ring-shaped body 100 can be grasped from the distance that the member 2 has slid and the distance.
  • the marker 7 does not need to completely block X-rays, and may be any X-ray transmittance that can detect the presence of the marker under fluoroscopy.
  • FIG. 5 is a perspective view of the first member 1 and the second member 2 of the ring-shaped body of FIG. 4 viewed from the B direction.
  • a stopper portion 8 is formed on the first member 1 and a stopper portion 9 is formed on the second member 2.
  • the first member 1 and the second member 2 slide with each other, and the first member 1 does not eventually come out of the second member 2, but the stopper portion 8 of the first member 1 and the second member 2.
  • the stopper portion 8 may be formed as a member different from the first member 1 or may be integrally formed with the first member 1.
  • FIG. 6 is a perspective view of the medical tubular body according to the first embodiment of the present invention.
  • the medical tubular body according to the present embodiment has a plurality of annular bodies 100 in the axial direction. This is because by forming a plurality of annular bodies 100, it is possible to set different diameter expansion amounts for each annular body 100 in accordance with the characteristics of the lesioned part of the lumen in the living body.
  • the balloon used for expanding the diameter of the medical tubular body can be constituted by a plurality of bag-like objects having different capacities.
  • Each ring-shaped body 100 may be the same (same mass), but when the ring-shaped body 100 contains a biodegradable substance, each ring-shaped body 100 may have a different mass.
  • each ring-shaped body 100 has the same mass, it is assumed that the time when each ring-shaped body 100 is completely disassembled is almost the same period, and the shape of the medical tubular body collapses at once. May affect the treatment of in vivo lumens.
  • each ring-shaped body 100 has a different mass, for example, the first member 1 and the second member 2 included in one ring-shaped body 100 and the first member 1 included in another ring-shaped body 100 are included.
  • the thickness of the second member 2 is different from that of the second member 2, it is possible to disperse the time when the ring-shaped body 100 collapses due to biodegradation, and to reduce the influence on the treatment of the in vivo lumen.
  • the adjacent ring-shaped bodies 100 are connected to each other via the column 10.
  • the support column 10 may be connected between the first member 1 and the second member 2, or between the first members 1 or between the second members 2. It may be connected.
  • the medical tubular body desirably has a radiopaque marker 11. This is for grasping the position of the medical tubular body in the body under fluoroscopy.
  • the marker 11 By providing the marker 11 inside the support column 10 (inward in the radial direction of the ring-shaped body 100), the marker 11 does not protrude outward from the ring-shaped body 100, so that stimulation to the inner wall of the body lumen can be reduced. it can.
  • the at least two markers 11 so that the positions in the axial direction when the diameter of the ring-shaped body 100 is reduced are different from each other, the markers 11 do not interfere with each other when the diameter of the ring-shaped body 100 is reduced. 100 can be reduced in diameter.
  • an injection molding method, a laser processing method, a mechanical cutting process, etching, three-dimensional printing, and the like can be suitably used.
  • the material constituting the marker 7 and the marker 11 is not particularly limited as long as the material has higher radiopacity than the constituent material of the annular body 100.
  • a metal material is preferable, and platinum, palladium, and tantalum are preferable in view of excellent biocompatibility particularly with respect to the human body.
  • tantalum is preferred because it has a small difference in electrochemical potential and is difficult to corrode.
  • the size of the medical tubular body is not particularly limited.
  • the outer diameter of the tubular body is, for example, about 0.36 to 0.46 mm when contracted, and about 4.0 to 4.5 mm when expanding, for example. It is.
  • FIG. 7 is a development view of the medical tubular body according to the second embodiment of the present invention.
  • the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
  • the annular body 100 of the medical tubular body according to the second embodiment of the present invention meanders.
  • the width of the meander (the axial length of the ring-shaped body 100) is W.
  • the balloon 100 disposed inside the annular body 100 expands to reduce the width W while the width W is reduced.
  • the ring-shaped body 100 of the medical tubular body according to the second embodiment is (1) the diameter expansion due to the first member 1 and the second member 2 sliding relative to each other, like the ring-shaped body 100 of the first embodiment.
  • the ring-shaped body 100 In order to make the ring-shaped body 100 meander, for example, as shown in FIG. 7, there is a method of connecting the first member 1 and / or the second member 2 to a fourth member 12 having a bent shape. Thereby, even if the 1st member 1 and / or the 2nd member 2 are members of a linear shape, the ring-shaped body 100 can be made to meander shape.
  • the fourth member 12 is preferably a plastic material. This is because the ring-shaped body 100 maintains the expanded diameter state even if the balloon or the like is removed after the diameter of the ring-shaped body 100 is increased by a balloon or the like.
  • an elastic material for the fourth member 12. This is because the elastic material has higher shape retention of the medical tubular body.
  • the first member 1 and the second member 2 slide in the circumferential direction even when stress is applied from the inside to the outside of the ring-shaped body 100. It is desirable to have a sliding drag that does not occur.
  • the meandering width W is reduced, thereby reducing the circumference of the ring-shaped body 100.
  • the ring-shaped body 100 has room to further expand its diameter, which means that the resistance of the first member 1 and the second member 2 to the slide is set higher than the stress in such a situation. If the ring-shaped body 100 is fully extended until the ring-shaped body 100 finally disappears, the diameter expansion due to the decrease in the meandering width W does not work, so the balloon 100 or the like moves from the radially inner side to the outer side. If a greater stress is applied, the first member 1 and the second member 2 begin to slide with each other in the same manner as the ring-shaped body 100 of the first embodiment, and the ring-shaped body 100 is further expanded in diameter.
  • the first member 1 and the second member 2 do not slide in the circumferential direction even when a stress is applied from the radially inner side to the outer side of the ring-shaped body 100.
  • the structure of having a certain level of sliding drag is that the first member 1 and the second member 2 slide relative to each other in the direction in which the circumference of the ring-shaped body 100 increases, such as when the first member 1 and the second member 2 have a ratchet mechanism or a slide and lock mechanism. This is particularly effective when it has a configuration that does not slide in the direction in which the circumference of the ring-shaped body 100 decreases.
  • the ring-shaped body 100 is expanded in diameter by reducing the meandering width W in the first stage of diameter expansion, and is adjusted and expanded by sliding the first member 1 and the second member 2 in the second stage of diameter expansion. A diameter is made.
  • the meandering ring-shaped body 100 has a merit that it can easily follow the movement of the lumen in the living body because of its high flexibility.
  • the state in which the ring-shaped body is meandering in the definition of "having a ring” means a state in which the meandering width W (maximum width) of the ring-shaped body is larger than 1/10 of the maximum diameter R of the ring-shaped body.
  • the “sliding drag” is the magnitude of the force required for the first member 1 and the second member 2 to start relative sliding from a stationary state. For example, in the case of the ratchet mechanism of FIG. If so, it is determined by the shape, number, rigidity, and the like of the convex portions 3 and the concave portions 4.
  • FIG. 8 is a development view of the medical tubular body according to the third embodiment of the present invention.
  • the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
  • the ring-shaped body 100 of the medical tubular body according to the third embodiment of the present invention has the width of the first member 1 and the width of the second member 2 in the axial direction of the ring-shaped body. Are different from each other.
  • the second member 2 has a wider width than the first member 1.
  • FIG. 9 is a development view of the medical tubular body according to the fourth embodiment of the present invention.
  • the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
  • the first member 1 and the second member 2 are adjacent to each other in the axial direction, whereas the medical member according to the fourth embodiment.
  • the first member 1 is arranged on the inner side than the second member 2.
  • the boundary portion between the two members (first member 1 and second member 2) that slide in opposite directions from each other hits the inner wall of a blood vessel or the like. You can avoid touching. Therefore, the probability that the blood vessel or the like is restenosis is reduced.
  • the 2nd member 2 is distribute

Abstract

The purpose of the present invention is to provide a medical tubular body which incurs less stimulus to the inner wall of a blood vessel and the like while having a configuration in which the diameter thereof is expandable. This medical tubular body has a ring-like body (100) the diameter of which is expandable, wherein the ring-like body (100) has a circumferential direction and an axial direction, and includes a first member (1) formed in a segment thereof in the circumferential direction, and a second member (2) formed in a segment thereof in the circumferential direction, the first member (1) and the second member (2) being slidably engaged with each other in the circumferential direction.

Description

医療用管状体Medical tubular body
 本発明は、拡径可能な医療用管状体に関するものであり、例えば、血管その他の生体内管腔が狭窄あるいは閉塞した病変部を治療するために用いられるものである。さらに詳しくは、生体内管腔の病変部に留置するステントに代表される医療用管状体、あるいは病変部に発生した血栓などを除去するために用いられる医療用管状体に関するものである。 The present invention relates to a medical tubular body that can be expanded in diameter, and is used, for example, to treat a lesion where a blood vessel or other in-vivo lumen is narrowed or occluded. More specifically, the present invention relates to a medical tubular body typified by a stent placed in a lesioned part of a living body lumen, or a medical tubular body used for removing a thrombus generated in a lesioned part.
 ステントに代表される医療用管状体は、一般に、血管その他の生体内管腔が狭窄あるいは閉塞することにより生じる様々な疾患を治療するための医療器具である。医療用管状体には、狭窄または閉塞部位等の病変部における管腔を内側から拡張し、その管腔内径を維持するために病変部に留置するもの、あるいは、病変部またはその周囲に発生した血栓などを絡め取り体外へ除去し、その病変部における管腔内径を回復させるもの等が挙げられる。 A medical tubular body typified by a stent is generally a medical instrument for treating various diseases caused by stenosis or occlusion of a blood vessel or other living body lumen. The medical tubular body has a lumen in the lesion such as a stenosis or occlusion that is expanded from the inside and is placed in the lesion to maintain the inner diameter of the lumen, or has occurred in or around the lesion. Examples include entanglement of a thrombus and the like to remove it from the body and recover the lumen inner diameter at the lesion.
 ステントのこのような拡径動作が可能となるよう、ステントを構成する輪状の部材(輪状体)は、その周長が増加し得るように構成されている。図10は、従来のステントの輪状体100の構成を示す斜視図である。図10に示されるように、輪状体100は、一端側に幅狭部101を有しており、幅狭部101は、輪状体100の一部に設けられた穴102を通して内側から外側へ導出されている。輪状体100の内部に配置されたバルーン(図示せず)が膨張することにより、輪状体100の内側から外側に向かって応力が働き、これに伴い輪状体100が拡径され、幅狭部101の導出長さが順次減少していく仕組みである。 The ring-shaped member (annular body) constituting the stent is configured so that the circumference thereof can be increased so that the diameter expansion operation of the stent can be performed. FIG. 10 is a perspective view showing the configuration of a conventional annular body 100 of a stent. As shown in FIG. 10, the ring-shaped body 100 has a narrow portion 101 on one end side, and the narrow portion 101 is led out from the inside to the outside through a hole 102 provided in a part of the ring-shaped body 100. Has been. When a balloon (not shown) arranged inside the ring-shaped body 100 is inflated, a stress acts from the inside to the outside of the ring-shaped body 100, and accordingly, the diameter of the ring-shaped body 100 is expanded, and the narrow portion 101. This is a mechanism in which the derivation length of s decreases gradually.
 より具体的には、例えば、特許文献1には、頭部と、この頭部から延設される細長い胴部からなるT字形ユニット部を複数個並設し、頭部において相互に連結されるように一体的に形成されたポリマーステントが記載されている。特許文献1のポリマーステントでは、各々の胴部を丸めて、頭部に形成されたスリットに挿入係止してリング形状にし、全体として筒状となるものである。 More specifically, for example, in Patent Document 1, a plurality of T-shaped unit portions including a head portion and an elongated body portion extending from the head portion are arranged side by side and are connected to each other at the head portion. A polymer stent that is integrally formed is described. In the polymer stent of Patent Document 1, each body portion is rounded and inserted into and locked in a slit formed in the head portion to form a ring shape, which becomes a tubular shape as a whole.
 また、特許文献2にも、複数の輪部構成片を有し、各輪部構成片は所要間隔をおいて接続片で互いに接続されて並設されているステントが記載されている。特許文献2のステントでは、各輪部構成片は、一端側に設けられている挿通口と、他端側に設けられており各輪部構成片を丸めたときに挿通口に湾曲内面側から外面側へ通される係止部と、係止部側を挿通口に通して輪部構成片が輪状となるようにし、係止部を湾曲外面側から内面側へ貫通させて係止部を係止した状態で、その係止位置が輪部構成片の径が拡張する方向の一方向だけに動くようにした複数の係止受部とを備えている。 Also, Patent Document 2 describes a stent that has a plurality of ring-shaped component pieces, and each ring-shaped component piece is connected to each other with a connecting piece at a necessary interval. In the stent of Patent Document 2, each ring component piece is provided on one end side, and the other end side is provided on the other end side. The locking part that is passed to the outer surface side, the locking part side is passed through the insertion port so that the ring component piece becomes a ring shape, and the locking part is penetrated from the curved outer surface side to the inner surface side so that the locking part is In the locked state, the locking position is provided with a plurality of locking receiving portions that move only in one direction in which the diameter of the ring component piece expands.
特開2011-251117号公報JP 2011-251117 A 再公表2011-021654号公報Republished 2011-021654
 従来の医療用管状体では、図10のステントの輪状体100に代表されるように、その一部(幅狭部101等)が、輪状体100の一部に設けられた穴102を通してステントの外側に突出した構造となっているため、血管内壁へ局所的な刺激が加わり、これにより血管に再狭窄が発生してしまう可能性がある。 In the conventional medical tubular body, as represented by the annular body 100 of the stent in FIG. 10, a part (the narrow portion 101 or the like) of the stent passes through the hole 102 provided in a part of the annular body 100. Since the structure protrudes outward, local stimulation is applied to the inner wall of the blood vessel, which may cause restenosis in the blood vessel.
 例えば特許文献1のステントでは、血管と触れる外表面に鈎状突起部が形成されることで、血管内壁へ刺激が加わり、これにより再狭窄が発生してしまう。特許文献2では、挿通口に通して輪状にする部分において、突起部が形成されてしまい、再狭窄の原因となる可能性がある。 For example, in the stent of Patent Document 1, a ridge-like protrusion is formed on the outer surface that comes into contact with a blood vessel, whereby stimulation is applied to the inner wall of the blood vessel, thereby causing restenosis. In Patent Document 2, a protrusion is formed in a ring-shaped portion passing through the insertion opening, which may cause restenosis.
 本発明は、拡径可能な構成を有しながらも、血管等の内壁への刺激が少ない医療用管状体を提供することを目的とするものである。 An object of the present invention is to provide a medical tubular body that has a structure capable of expanding its diameter and has little irritation to an inner wall of a blood vessel or the like.
 すなわち上記課題を解決し得た本発明の医療用管状体は、拡径可能な輪状体を有する医療用管状体であって、前記輪状体は、周方向と軸方向を有し、周方向の一部区間に形成されている第1部材と、周方向の一部区間に形成されている第2部材とを有しており、前記第1部材と前記第2部材とが互いに周方向にスライド可能に係合しているものである。本発明では、輪状体100が拡径可能な構成を有しながらも、上述した従来の輪状体100(図10)に比べて輪状体100から外方へ突出する部分が少なく、そのため血管等の生体内管腔内壁への刺激が少ないものである。 That is, the medical tubular body of the present invention that has solved the above-described problems is a medical tubular body having a ring-shaped body that can be expanded in diameter, and the ring-shaped body has a circumferential direction and an axial direction. It has the 1st member currently formed in the partial area, and the 2nd member formed in the partial area of the circumferential direction, The said 1st member and the said 2nd member slide mutually in the circumferential direction Engageable. In the present invention, while the ring-shaped body 100 has a configuration capable of expanding the diameter, the portion protruding outward from the ring-shaped body 100 is smaller than the conventional ring-shaped body 100 (FIG. 10) described above. There is little irritation to the inner wall of the lumen in the living body.
 上記医療用管状体において、前記第1部材と前記第2部材とは、前記輪状体の周長が増加する方向には互いにスライド可能であり、前記輪状体の周長が減少する方向には互いにスライドしないことが望ましい。 In the medical tubular body, the first member and the second member are slidable in a direction in which the circumference of the annular body increases, and are mutually in a direction in which the circumference of the annular body decreases. It is desirable not to slide.
 上記医療用管状体において、前記第1部材には、前記第2部材に対向する面に、凸部が形成されており、前記第2部材には、前記第1部材に対向する面に、凹部が形成されており、前記凸部または前記凹部の少なくとも一方は、周方向に異方形状を有していることが望ましい。 In the medical tubular body, a convex portion is formed on a surface of the first member that faces the second member, and a concave portion is formed on the surface of the second member that faces the first member. It is desirable that at least one of the convex part or the concave part has an anisotropic shape in the circumferential direction.
 上記医療用管状体において、前記第1部材および前記第2部材に、X線不透過性のマーカーが形成されていることが望ましい。 In the medical tubular body, it is desirable that radiopaque markers are formed on the first member and the second member.
 上記医療用管状体において、前記第1部材および前記第2部材は、それぞれ、互いに当接し合うストッパー部を含むことが望ましい。 In the medical tubular body, it is desirable that the first member and the second member each include a stopper portion that contacts each other.
 上記医療用管状体において、複数の前記輪状体を有していることが望ましい。 It is desirable that the medical tubular body has a plurality of the annular bodies.
 上記医療用管状体において、前記複数の輪状体は、互いに異なる質量を有していることが望ましい。 In the medical tubular body, it is preferable that the plurality of annular bodies have different masses.
 上記医療用管状体において、前記複数の輪状体どうしが支柱を介して接続されていることが望ましい。 In the medical tubular body, it is preferable that the plurality of ring-shaped bodies are connected to each other through a support column.
 上記医療用管状体において、前記支柱が複数存在しており、各支柱にはX線不透過性のマーカーが配されており、各マーカーの軸方向の位置は互いに異なっていることが望ましい。 In the above-described medical tubular body, it is desirable that a plurality of the support columns exist, and each support column is provided with a radiopaque marker, and the positions of the markers in the axial direction are different from each other.
 上記医療用管状体において、前記輪状体は蛇行しており、蛇行の幅は、前記輪状体の拡径に伴い減少するものであることが望ましい。 In the medical tubular body, the annular body is meandering, and the width of the meandering is preferably reduced as the diameter of the annular body increases.
 上記医療用管状体において、前記輪状体が蛇行している状態においては、前記輪状体の径方向の内方から外方に向かう応力を負荷しても、前記第1部材と前記第2部材は、周方向に互いにスライドしない程度のスライド抗力を有していることが望ましい。 In the medical tubular body, in the state where the annular body is meandering, the first member and the second member are not affected even when a stress is applied from the radially inner side to the outer side of the annular body. It is desirable to have a sliding drag that does not slide in the circumferential direction.
 上記医療用管状体において、前記輪状体の軸方向における、前記第1部材の幅と前記第2部材の幅は、互いに異なるものであることが望ましい。 In the medical tubular body, it is desirable that a width of the first member and a width of the second member in the axial direction of the annular body are different from each other.
 上記医療用管状体において、前記第1部材と前記第2部材とは互いに軸方向に隣接している態様が好ましく実施し得る。 In the above-described medical tubular body, an embodiment in which the first member and the second member are adjacent to each other in the axial direction can be preferably implemented.
 上記医療用管状体において、前記第1部材および前記第2部材は、一方よりも他方が内側に配されている態様が好ましく実施し得る。 In the above-described medical tubular body, an embodiment in which the first member and the second member are arranged more inside than the other can be preferably implemented.
 上記医療用管状体において、前記輪状体が生分解性物質を含むことが望ましい。 In the medical tubular body, it is desirable that the annular body contains a biodegradable substance.
 本発明の医療用管状体は、周方向の一部区間に形成されている第1部材と、周方向の一部区間に形成されている第2部材とを有する輪状体を備え、第1部材と第2部材とが互いに周方向にスライド可能に係合して形成されているため、拡径可能な構成を有しながらも輪状体から外方へ突出する部材が少なく、そのため血管等の内壁への刺激が少ない。本発明では、このように、生体内管腔が再狭窄する確率を低減し得る医療用管状体を提供することができる。 The medical tubular body of the present invention includes a ring-shaped body having a first member formed in a partial section in the circumferential direction and a second member formed in a partial section in the circumferential direction. And the second member are slidably engaged with each other in the circumferential direction, so that there are few members projecting outward from the ring-shaped body while having a configuration capable of expanding the diameter, so that the inner wall of a blood vessel or the like There is little irritation. Thus, the present invention can provide a medical tubular body that can reduce the probability of restenosis of a living body lumen.
図1は、本発明の実施の形態1にかかる医療用管状体の輪状体の斜視図である。1 is a perspective view of a ring-shaped body of a medical tubular body according to a first embodiment of the present invention. 図2は、図1の輪状体のA部の拡大分解図である。FIG. 2 is an enlarged exploded view of a portion A of the ring-shaped body of FIG. 図3は、図1の輪状体のA部の拡大図であり、第1部材と第2部材とが係合している状態を示す図である。FIG. 3 is an enlarged view of a portion A of the ring-shaped body of FIG. 1 and shows a state where the first member and the second member are engaged. 図4は、図3の輪状体の第1部材と第2部材とが互いにスライドする様子を示す図である。FIG. 4 is a diagram illustrating a state in which the first member and the second member of the annular body in FIG. 3 slide with each other. 図5は、図4の輪状体の第1部材と第2部材をB方向から見た斜視図である。FIG. 5 is a perspective view of the first member and the second member of the ring-shaped body of FIG. 4 as viewed from the B direction. 図6は、本発明の実施の形態1にかかる医療用管状体の斜視図である。FIG. 6 is a perspective view of the medical tubular body according to the first embodiment of the present invention. 図7は、本発明の実施の形態2にかかる医療用管状体の展開図である。FIG. 7 is a development view of the medical tubular body according to the second embodiment of the present invention. 図8は、本発明の実施の形態3にかかる医療用管状体の斜視図である。FIG. 8 is a perspective view of the medical tubular body according to the third embodiment of the present invention. 図9は、本発明の実施の形態4にかかる医療用管状体の斜視図である。FIG. 9 is a perspective view of a medical tubular body according to the fourth embodiment of the present invention. 図10は、従来の輪状体の斜視図である。FIG. 10 is a perspective view of a conventional ring-shaped body.
 本発明の実施の形態にかかる医療用管状体を詳細に説明する前に、医療用管状体の一般的構成を説明しておく。なお、本明細書においては、医療用管状体から、X線不透過材料で構成されたマーカーを除いた構成を「管状体」と呼ぶこととする。この管状体は、一つまたは複数の輪状体を含んでいる。 Before describing in detail the medical tubular body according to the embodiment of the present invention, the general configuration of the medical tubular body will be described. In the present specification, a configuration in which a marker made of a radiopaque material is removed from a medical tubular body is referred to as a “tubular body”. The tubular body includes one or a plurality of ring-shaped bodies.
(1)医療用管状体の用途
 医療用管状体は、生体内管腔内で用いられるものであり、例えば生体内管腔の病変部に留置して生体内管腔の径を維持ないし拡張するためのステントや、生体内管腔に形成された血栓を除去するための血栓回収デバイス、或いは末梢保護デバイス(末梢保護フィルター)等が挙げられる。
(1) Use of medical tubular body The medical tubular body is used in a living body lumen. For example, it is placed in a lesioned part of a living body lumen to maintain or expand the diameter of the living body lumen. For example, a thrombectomy device for removing a thrombus formed in a lumen in a living body, or a peripheral protection device (peripheral protection filter).
(2)医療用管状体の分類
 医療用管状体には、例えば、(i)1本の線状の金属もしくは高分子材料からなるコイル状のタイプ、(ii)金属チューブをレーザーなどで切り抜き加工したタイプ、(iii)線状の部位を溶接し組み立てたタイプ、(iv)複数の線状金属を織って作ったタイプ等がある。
(2) Classification of medical tubular bodies For medical tubular bodies, for example, (i) a coiled type made of a single linear metal or polymer material, and (ii) a metal tube cut out with a laser or the like (Iii) a type in which linear portions are welded and assembled, and (iv) a type in which a plurality of linear metals are woven.
 医療用管状体は、病変部まで搬送(デリバリー)するために医療用管状体を設置する部位を有するカテーテル(デリバリーシステム:搬送装置)等に取り付けて用いられている。医療用管状体の拡張機構の観点からの分類としては、(i)バルーン外表面上に医療用管状体を装着(マウント)して病変部まで搬送し、病変部でバルーンによって医療用管状体を拡張するバルーン拡張型と、(ii)拡張を抑制する部材を有するカテーテルで病変部に搬送し、病変部で拡張を抑制する部材を取り外すことにより自ら拡張する自己拡張型とに分けることができる。 The medical tubular body is used by being attached to a catheter (delivery system: delivery device) or the like having a portion where the medical tubular body is placed for delivery (delivery) to a lesioned part. The classification from the viewpoint of the expansion mechanism of the medical tubular body includes (i) mounting (mounting) the medical tubular body on the outer surface of the balloon and transporting it to the lesioned area, It can be divided into a balloon expandable type that expands and a self-expandable type that expands by itself by removing the member that suppresses expansion at the lesioned part by transporting it to the lesioned part with a catheter having a member that suppresses expansion.
 医療用管状体は、バルーンやカテーテル等からなるデリバリーシステム内に設置された状態においては、管状体の長手方向軸に直交する方向(管の半径方向)には縮小し、長手軸方向には伸びることにより、拡張状態よりも細長い円筒状の形態(縮径状態)となる。自己拡張型では内部にバルーンを設けなくてもよいことから、バルーン拡張型に比べて縮径状態の径を小さくすることができる。 In a state where the medical tubular body is installed in a delivery system composed of a balloon, a catheter, or the like, the medical tubular body contracts in the direction perpendicular to the longitudinal axis of the tubular body (the radial direction of the tube) and extends in the longitudinal axis direction. By this, it becomes a cylindrical shape (reduced diameter state) which is longer than the expanded state. In the self-expanding type, since it is not necessary to provide a balloon inside, the diameter of the reduced diameter state can be reduced as compared with the balloon expansion type.
(3)管状体
 管状体は、例えば輪状体の集合で構成されており、輪状体は、帯状の部材の周長を伸ばす構造を有する拡径可能な構造体である。本発明において拡径可能とは、管状体の長軸に垂直な方向(径方向)に伸張することができるものである。管状体は、径が伸張された状態からは逆に収縮(縮径)できてもよいし、ラチェット機構を有し、拡径はできても縮径はできない構成とされていてもよい。管状体は、例えば周方向及び軸方向に伸縮する、相互に連結している構造要素のパターンから形成される。本発明において管状体は、任意のパターンに適用可能であり、したがって、いかなる特定のステントの形状あるいは構造要素のパターンにも限定されない。
(3) Tubular body The tubular body is composed of, for example, a group of ring-shaped bodies, and the ring-shaped body is a structure that can be expanded in diameter and has a structure that extends the circumference of a band-shaped member. In the present invention, “expandable diameter” means that the tube can be extended in a direction (radial direction) perpendicular to the long axis of the tubular body. The tubular body may be contracted (reduced diameter) in reverse from the state in which the diameter is expanded, or may have a ratchet mechanism so that the diameter can be increased but not reduced. The tubular body is formed, for example, from a pattern of interconnected structural elements that expand and contract in the circumferential and axial directions. The tubular body in the present invention can be applied in any pattern and is therefore not limited to any particular stent shape or structural element pattern.
(4)マーカー
 医療用管状体をひとたび体内に入れると、その位置を目視で確認することはできない。そのため、X線透視下において医療用管状体を観察できるよう、医療用管状体の所定位置にX線不透過材料を含むマーカーが設けられる。マーカーは、X線を完全に遮断するものでなくてもよく、X線透視下においてマーカーの存在が検知できる程度のX線透過率であればよい。
(4) Marker Once the medical tubular body is placed in the body, its position cannot be confirmed visually. Therefore, a marker including a radiopaque material is provided at a predetermined position of the medical tubular body so that the medical tubular body can be observed under fluoroscopy. The marker does not need to completely block X-rays, and may be any X-ray transmittance that can detect the presence of the marker under fluoroscopy.
(実施の形態1)
 以下、本発明の実施の形態1にかかる医療用管状体の構成要素である輪状体について、図面を用いて説明する。
(Embodiment 1)
Hereinafter, an annular body that is a component of the medical tubular body according to the first embodiment of the present invention will be described with reference to the drawings.
 図1は、本発明の実施の形態1にかかる医療用管状体の輪状体の斜視図である。図1において、輪状体100は、周方向と軸方向を有し、周方向の一部区間に形成されている第1部材1と、周方向の一部区間に形成されている第2部材2とを有している。第1部材1が形成されている周方向の一部区間というのは、周方向の全周を除く意味であるが、周方向のどの場所であるかについては限定されない。また、第2部材2についても同様に周方向の一部区間に形成されるものであるが、第1部材1と第2部材2とは互いに係合していればよく、その限りにおいて、第2部材2は、第1部材1と同じ区間に形成されているものであるか、或いは第1部材1とは別の区間に形成されているものであるかについては限定されない。 FIG. 1 is a perspective view of a ring-shaped body of a medical tubular body according to the first embodiment of the present invention. In FIG. 1, a ring-shaped body 100 has a circumferential direction and an axial direction, and a first member 1 formed in a partial section in the circumferential direction and a second member 2 formed in a partial section in the circumferential direction. And have. The partial section in the circumferential direction in which the first member 1 is formed has the meaning of excluding the entire circumference in the circumferential direction, but the place in the circumferential direction is not limited. Similarly, the second member 2 is also formed in a partial section in the circumferential direction, but the first member 1 and the second member 2 may be engaged with each other. It is not limited whether the two members 2 are formed in the same section as the first member 1 or are formed in a section different from the first member 1.
 このように形成されている第1部材1と第2部材2との互いの重なり部分が減る方向にスライドすれば、輪状体100の周長は増大し、その結果、輪状体100は拡径される。 If the first member 1 and the second member 2 formed in this way are slid in the direction in which the overlapping portions of the first member 1 and the second member 2 decrease, the circumference of the annular body 100 increases, and as a result, the annular body 100 is expanded in diameter. The
 以上のように、本発明の実施の形態1にかかる医療用管状体は、第1部材1と第2部材2がスライドする構成であるため、拡径可能な構成を有しながらも図10の場合に比べて、輪状体100から外方へ突出する部分が少なく、そのため血管等の生体内管腔内壁への刺激が少ない。したがって、生体内管腔が再狭窄する確率を低減し得る。 As described above, the medical tubular body according to the first embodiment of the present invention has a configuration in which the first member 1 and the second member 2 slide, so that the configuration shown in FIG. Compared to the case, there are few portions projecting outward from the ring-shaped body 100, and therefore there is less stimulation to the inner wall of the body lumen such as blood vessels. Therefore, the probability that the in-vivo lumen is restenosis can be reduced.
 なお、本発明における輪状体100の形状は、最も典型的には円形状のものであるが円形状に限らず、楕円形状、四角枠状のものも含み、輪状体の幅(軸方向の長さ)も限定されない。 The shape of the annular body 100 in the present invention is most typically a circular shape, but is not limited to a circular shape, and includes an elliptical shape and a rectangular frame shape. Sa) is not limited.
 本実施の形態にかかる医療用管状体は、上記のように互いに係合する第1部材1と第2部材2とのスライドにより輪状体の周長を伸ばすことができることに要旨があるため、第1部材1と第2部材2の他に、例えば、周方向の一部区間に形成され、第2部材2と周方向において重なっている第3部材(図示せず)を更に有していてもよい。この場合において、第2部材2と第3部材とは互いに周方向にスライド可能に係合していてもよいし、第2部材2と第3部材とはスライドせず互いに固定されていてもよい。 Since the medical tubular body according to the present embodiment has the gist that the circumference of the annular body can be extended by sliding the first member 1 and the second member 2 engaged with each other as described above, In addition to the first member 1 and the second member 2, for example, it may further include a third member (not shown) formed in a partial section in the circumferential direction and overlapping the second member 2 in the circumferential direction. Good. In this case, the second member 2 and the third member may be slidably engaged with each other in the circumferential direction, or the second member 2 and the third member may be fixed to each other without sliding. .
 輪状体100は、図1のように、複数の第1部材1と複数の第2部材2とを含み、第1部材1と第2部材2とが周方向に交互に、かつ、軸方向に交互に係合されることにより形成されていてもよい。このような構成とすることにより、輪状体100が軸方向の狭い範囲で形成されるため、輪状体100の形状が歪みにくい。 As shown in FIG. 1, the ring-shaped body 100 includes a plurality of first members 1 and a plurality of second members 2, and the first members 1 and the second members 2 are alternately arranged in the circumferential direction and in the axial direction. You may form by engaging alternately. By adopting such a configuration, the ring-shaped body 100 is formed in a narrow range in the axial direction, so that the shape of the ring-shaped body 100 is not easily distorted.
 第1部材1と第2部材2の係合の構造や方式は特に限定されない。詳細は後述するが、例えば、第1部材1或いは第2部材2にガイド用のレールや溝が設けられていてもよい。第1部材1と第2部材2とは、滑りをよくするために互いに線接触していてもよく、或いは、滑り難くするために互いに面接触していてもよい。 The structure and method of engagement between the first member 1 and the second member 2 are not particularly limited. Although details will be described later, for example, the first member 1 or the second member 2 may be provided with guide rails or grooves. The first member 1 and the second member 2 may be in line contact with each other in order to improve slippage, or may be in surface contact with each other in order to make slippage difficult.
 本実施の形態にかかる医療用管状体は、好ましくは更に以下の構成を含むことができる。例えば、第1部材1と第2部材2とが、輪状体100の周長が増加する方向(つまり輪状体100の拡径方向)には互いにスライド可能に構成されているが、輪状体100の周長が減少する方向(つまり輪状体100の縮径方向)には互いにスライドしない構成とすることもできる。例えば、輪状体100にラチェット機構を持たせることにより、医療用管状体に段階的かつ不可逆的な拡径動作をさせることができる。すなわち、医療用管状体の内側に配置されたバルーンが膨張することにより医療用管状体は拡径するが、バルーンによる応力が取り除かれても医療用管状体は縮径せず、拡径された状態を維持することができる。 The medical tubular body according to the present embodiment can preferably further include the following configuration. For example, the first member 1 and the second member 2 are configured to be slidable in the direction in which the circumference of the ring-shaped body 100 increases (that is, the diameter-enlarging direction of the ring-shaped body 100). It is also possible to adopt a configuration in which they do not slide with respect to each other in the direction in which the circumferential length decreases (that is, the diameter reduction direction of the annular body 100). For example, by providing the ring-shaped body 100 with a ratchet mechanism, it is possible to cause the medical tubular body to perform a stepwise and irreversible diameter expansion operation. That is, when the balloon disposed inside the medical tubular body is inflated, the diameter of the medical tubular body is expanded, but the medical tubular body is not reduced in diameter even if the stress by the balloon is removed. The state can be maintained.
 以上のように、輪状体100にラチェット機構を採用する他、例えば、第1部材1と第2部材2との間に一定の静摩擦抵抗を持たせることにより、同様に、バルーンによる内側からの応力がなくなっても、静摩擦により医療用管状体は縮径せず、拡径された状態を維持することができる。 As described above, in addition to employing the ratchet mechanism for the ring-shaped body 100, for example, by giving a constant static friction resistance between the first member 1 and the second member 2, similarly, the stress from the inside caused by the balloon Even if there is not, the medical tubular body is not reduced in diameter by static friction, and the expanded diameter can be maintained.
 図2は、図1の輪状体のA部の拡大分解図である。輪状体100にラチェット機構を持たせるために、第1部材1には、第2部材2に対向する面に、凸部3が形成されており、第2部材2には、第1部材1に対向する面に、凹部4が形成されており、凸部3と凹部4とが嵌合することにより第1部材1と第2部材2との位置関係が固定される。そして、凸部3または凹部4の少なくとも一方は、輪状体100の周方向に異方形状を有しているため、周方向の一方方向へはスライドしやすいが、他方方向にはスライドしにくい、或いはスライドできない構造となる。なお、図示していないが、第1部材1に凹部4が形成され、第2部材2に凸部3が形成されていてもよい。また、上述のように第3部材を用いる場合は、第2部材2は、第1部材1との間で係合するため、および、第3部材との間で係合するため、第2部材2において第1部材1に対向する側に凸部3または凹部4を形成し、第3部材に対向する側に凸部3または凹部4を形成してもよい。 FIG. 2 is an enlarged exploded view of part A of the ring-shaped body of FIG. In order to provide the ring-shaped body 100 with a ratchet mechanism, the first member 1 is formed with a convex portion 3 on the surface facing the second member 2, and the second member 2 has the first member 1 with the first member 1. A concave portion 4 is formed on the opposing surface, and the positional relationship between the first member 1 and the second member 2 is fixed by fitting the convex portion 3 and the concave portion 4 together. And since at least one of the convex part 3 or the recessed part 4 has an anisotropic shape in the circumferential direction of the ring-shaped body 100, it is easy to slide in one direction of the circumferential direction, but difficult to slide in the other direction. Or it becomes a structure which cannot slide. Although not shown, the concave portion 4 may be formed on the first member 1 and the convex portion 3 may be formed on the second member 2. When the third member is used as described above, the second member 2 is engaged with the first member 1 and is engaged with the third member. 2, the convex portion 3 or the concave portion 4 may be formed on the side facing the first member 1, and the convex portion 3 or the concave portion 4 may be formed on the side facing the third member.
 第1部材1と第2部材2とがスムーズにスライドされるためには、第1部材1と第2部材2の材料として弾性のある材料、例えば樹脂を用いることが好ましい。第1部材1と第2部材2が樹脂材料で構成されていれば、凸部3は、応力が掛かる方向に倒れやすくなるため、第1部材1と第2部材2とをスライドさせやすくなる。 In order for the first member 1 and the second member 2 to slide smoothly, it is preferable to use an elastic material such as a resin as the material of the first member 1 and the second member 2. If the 1st member 1 and the 2nd member 2 are comprised with the resin material, since the convex part 3 will fall easily in the direction where stress is applied, it will become easy to slide the 1st member 1 and the 2nd member 2. FIG.
 第1部材1および第2部材2に使用される材料としては、拡径、縮径などの変形時や留置時の強度的な負荷に耐え得る材料であれば特に限定されるものではないが、医療用ステンレスである316Lステンレス、タンタル、Co-Cr(コバルトクロム)合金、Ni-Ti(ニッケル-チタン)合金等を好ましく用いることができる。特に、弾性特性を有し、加工性にも優れる点でニッケル-チタン合金を好ましく用いることができる。また、ニッケル-チタン合金の中でも、特に約50質量%~約60質量%のニッケルを含む合金を好ましく用いることができる。 The material used for the first member 1 and the second member 2 is not particularly limited as long as it is a material that can withstand a strong load at the time of deformation or indwelling, such as expansion or contraction. 316L stainless steel, tantalum, Co—Cr (cobalt chromium) alloy, Ni—Ti (nickel-titanium) alloy, etc., which are medical stainless steels, can be preferably used. In particular, a nickel-titanium alloy can be preferably used because it has elastic characteristics and is excellent in workability. Of the nickel-titanium alloys, an alloy containing about 50% by mass to about 60% by mass of nickel can be preferably used.
 他方、医療用管状体は、人体内に留置されるものであるため、術後の血管等の変形や金属アレルギーの患者等のことを考慮すると、第1部材1と第2部材2は、生分解性物質、例えば生分解性のポリマー又は金属を含むことが望ましい。生分解性材料は、少なくとも2種類の生分解性のポリマー及び/又は金属の複合物であってもよい。生分解性物質として使用可能な材料としては、例えば、ポリ乳酸、ポリカプロラクトン、ポリヒドロキシブチレート、ポリグリコール酸、シルクエラスチンポリマー、ポリヒドロキシ酸共重合体、ポリエステル、多糖類や、これらを1種以上含む組成物が挙げられる。 On the other hand, since the medical tubular body is indwelled in the human body, the first member 1 and the second member 2 are viable when taking into account the deformation of blood vessels after surgery and patients with metal allergies. It is desirable to include a degradable material, such as a biodegradable polymer or metal. The biodegradable material may be a composite of at least two biodegradable polymers and / or metals. Examples of materials that can be used as biodegradable substances include polylactic acid, polycaprolactone, polyhydroxybutyrate, polyglycolic acid, silk elastin polymer, polyhydroxy acid copolymer, polyester, polysaccharide, and one of these. The composition containing the above is mentioned.
 凸部3は、1つの第1部材1に対して複数設けられていることが好ましい。また、凹部4は、1つの第2部材2に対して複数設けられていることが好ましい。凸部3の数と凹部4の数に特に制限はないが、鋭角の構造となりやすい凸部3の数を凹部4の数よりも少なくすることにより、第1部材1と第2部材2とが係合していない区間において凸部3が露出し、生体内管腔内壁に当接し得る状態を回避することができる。また、凸部3が、第1部材1の長さ方向(輪状体100の周方向)の全体に亘って配置されるのではなく、第1部材1の長さ方向の一部区間にのみ設けられる構成としても、凸部3が露出して生体内管腔内壁に当接し得る状態を回避することができる。 It is preferable that a plurality of convex portions 3 are provided for one first member 1. In addition, it is preferable that a plurality of recesses 4 are provided for one second member 2. The number of the convex portions 3 and the number of the concave portions 4 are not particularly limited, but the first member 1 and the second member 2 can be reduced by reducing the number of the convex portions 3 that are likely to have an acute angle structure to be smaller than the number of the concave portions 4. The convex part 3 is exposed in the section which is not engaged, and the state which can contact | abut to a living body lumen inner wall can be avoided. Further, the convex portion 3 is not disposed over the entire length direction of the first member 1 (the circumferential direction of the ring-shaped body 100), but is provided only in a partial section in the length direction of the first member 1. Even in such a configuration, it is possible to avoid a state in which the convex portion 3 is exposed and can come into contact with the inner wall of the living body lumen.
 図2に示すように、凸部3は、第1部材1の径方向の内方に偏在していることが望ましい。第1部材1の径方向の外方は、生体内管腔内壁に当接し得る部分であり、凸部3の複雑な形状が生体内管腔に与える影響を低減するためである。同様に、凹部4は、第2部材2の径方向の内方に偏在していることが望ましい。第2部材2の径方向の外方も、生体内管腔に当接し得る部分であり、凹部4の複雑な形状が生体内管腔内壁に与える影響を低減するためである。 As shown in FIG. 2, it is desirable that the convex portion 3 is unevenly distributed inward in the radial direction of the first member 1. The outer side of the first member 1 in the radial direction is a portion that can come into contact with the inner wall of the in-vivo lumen, in order to reduce the influence of the complicated shape of the convex portion 3 on the in-vivo lumen. Similarly, it is desirable that the recess 4 is unevenly distributed inward in the radial direction of the second member 2. The outer side of the second member 2 in the radial direction is also a portion that can come into contact with the in-vivo lumen, in order to reduce the influence of the complicated shape of the recess 4 on the inner wall of the in-vivo lumen.
 凸部3が生体内管腔内壁に当接しない構成が取られていれば、凸部3が、第1部材1の長さ方向の全体に亘って配置されていても、凸部3が生体内管腔内壁に当接し得る問題は解消されやすい。凹部4についても同様である。 If the configuration in which the convex portion 3 is not in contact with the inner wall of the living body lumen is taken, even if the convex portion 3 is arranged over the entire length direction of the first member 1, the convex portion 3 is formed. Problems that may abut against the inner wall of the body lumen are likely to be solved. The same applies to the recess 4.
 好ましくは、第1部材1は、図2に示すように輪状体100の軸方向(一方)でかつ輪状体の径方向(内方)にある上段1aと、輪状体100の軸方向(他方)でかつ輪状体100の径方向(外方)にある下段1bとを有し、上段1aに凸部3を有している。また、第2部材2は、図2に示すように輪状体100の軸方向(一方)でかつ輪状体100の径方向(内方)にある下段2bと、輪状体100の軸方向(他方)でかつ輪状体100の径方向(外方)にある上段2aとを有し、下段2bに凹部4を有している。第1部材1と第2部材2をこのように形成することにより、凸部3或いは凹部4が、輪状体100の外方にある生体内管腔内壁に当接し得る問題は解消されやすい。 Preferably, as shown in FIG. 2, the first member 1 includes an upper stage 1 a that is in the axial direction (one side) of the annular body 100 and in the radial direction (inward) of the annular body 100, and the axial direction (other side) of the annular body 100. And the lower stage 1b in the radial direction (outward) of the ring-shaped body 100, and the convex part 3 on the upper stage 1a. Further, as shown in FIG. 2, the second member 2 includes a lower stage 2 b in the axial direction (one side) of the annular body 100 and in the radial direction (inward) of the annular body 100, and the axial direction (other side) of the annular body 100. And an upper stage 2a in the radial direction (outward) of the ring-shaped body 100, and a recess 4 in the lower stage 2b. By forming the 1st member 1 and the 2nd member 2 in this way, the problem that the convex part 3 or the recessed part 4 can contact | abut to the living body lumen inner wall in the outer side of the annular body 100 is easy to be solved.
 その他、凸部3は、第1部材1の内部に形成され、第1部材1の径方向の外方にも内方にも露出していないことが望ましい。凹部4についても同様であり、第2部材2の内部に形成され、第2部材2の径方向の外方にも内方にも露出していないことが望ましい。 In addition, it is desirable that the convex portion 3 is formed inside the first member 1 and is not exposed outwardly or inwardly in the radial direction of the first member 1. The same applies to the concave portion 4, and it is desirable that the concave portion 4 is formed inside the second member 2, and is not exposed outwardly or inwardly in the radial direction of the second member 2.
 図2に示すように、第1部材1には、輪状体100の周方向、すなわち第1部材1の周方向に延びる溝5が形成されており、他方、第2部材2には、溝5に嵌合される突起形状のガイド部6が形成されている。溝5とガイド部6との嵌合により、第1部材1と第2部材2とが互いに離れてしまわないように位置決めされている。ガイド部6は、凸部3の突起方向に対して直交する方向に突起していることが望ましい。例えば、図2に示すように凸部3の突起方向が輪状体100の軸方向である場合、ガイド部6は、輪状体100の径方向に突起しているものであることが好ましい。このような構成、すなわち凸部3と凹部4との嵌合方向(輪状体100の軸方向)と、溝5とガイド部6との嵌合方向(輪状体100の径方向)とが異なるものであることにより(より好ましくは直交していることにより)、第1部材1と第2部材2との係合が確実なものとなる。なお、ガイド部6は、第2部材2の周方向に延びるものであってもよいし、第2部材2の一部区間のみに設けられるものであってもよい。 As shown in FIG. 2, a groove 5 extending in the circumferential direction of the ring-shaped body 100, that is, in the circumferential direction of the first member 1 is formed in the first member 1, while the groove 5 is formed in the second member 2. A protrusion-shaped guide portion 6 is formed to be fitted to. The first member 1 and the second member 2 are positioned so as not to be separated from each other by the fitting between the groove 5 and the guide portion 6. It is desirable that the guide portion 6 protrudes in a direction orthogonal to the protrusion direction of the convex portion 3. For example, as shown in FIG. 2, when the protruding direction of the convex portion 3 is the axial direction of the annular body 100, the guide portion 6 is preferably protruded in the radial direction of the annular body 100. Such a configuration, that is, a fitting direction of the convex portion 3 and the concave portion 4 (axial direction of the annular body 100) and a fitting direction of the groove 5 and the guide portion 6 (radial direction of the annular body 100) are different. By being (more preferably by being orthogonal), the engagement between the first member 1 and the second member 2 is ensured. In addition, the guide part 6 may extend in the circumferential direction of the second member 2 or may be provided only in a partial section of the second member 2.
 図3は、図1の輪状体のA部の拡大図であり、第1部材1と第2部材2とが係合している状態を示す図である。図4は、図3の輪状体の第1部材1と第2部材2とが互いにスライドする様子を示す図である。図3および図4に示すように、凸部3および凹部4は、周方向に異方形状を有することが好ましく、この場合、第1部材1と第2部材2とは、一方方向にスライドしやすいが、逆方向にはスライドしにくく、或いは、スライドできない。例えば、図2~図4に示すように、凸部3は周方向の一方側に傾いており、凸部3の突起先端部は、凸部3の基部よりも周方向の一方側にずれた位置にある。そのため、第1部材1は、周方向の他方方向にスライドしやすいが、その逆の、周方向の一方方向にはスライドしにくい。凸部3が傾斜していない場合は、凹部4が傾斜していることが望ましい。具体的には、図2~図4に示すように、凹部4の底部(凸部3の突起先端部に対応する箇所)は、凹部4の開口部(凸部3の基部に対応する箇所)よりも周方向の一方側にずれている。もちろん、凸部3と凹部4の双方が周方向に異方形状を有することが好ましい。 FIG. 3 is an enlarged view of a portion A of the ring-shaped body of FIG. 1 and shows a state in which the first member 1 and the second member 2 are engaged. FIG. 4 is a diagram illustrating a state in which the first member 1 and the second member 2 of the annular body in FIG. 3 slide with each other. As shown in FIGS. 3 and 4, the convex portion 3 and the concave portion 4 preferably have an anisotropic shape in the circumferential direction. In this case, the first member 1 and the second member 2 slide in one direction. Easy, but difficult to slide in the reverse direction or cannot slide. For example, as shown in FIGS. 2 to 4, the convex portion 3 is inclined to one side in the circumferential direction, and the protrusion tip portion of the convex portion 3 is shifted to one side in the circumferential direction from the base portion of the convex portion 3. In position. Therefore, although the 1st member 1 is easy to slide to the other direction of the circumferential direction, it is hard to slide to the opposite one direction of the circumferential direction. When the convex part 3 is not inclined, it is desirable that the concave part 4 is inclined. Specifically, as shown in FIGS. 2 to 4, the bottom of the recess 4 (the location corresponding to the protrusion tip of the projection 3) is the opening of the recess 4 (the location corresponding to the base of the projection 3). Rather than one side in the circumferential direction. Of course, it is preferable that both the convex part 3 and the recessed part 4 have an anisotropic shape in the circumferential direction.
 図3および図4に示されるように、第1部材1および第2部材2に、X線不透過性のマーカー7が形成されていることが好ましい。医療用管状体が体内に入ると、輪状体100の拡径の度合いを定量的に確認することはできない。そこで、第1部材1および第2部材2の所定の位置にX線不透過性のマーカー7を形成しておくことにより、各マーカー7の相対的な位置関係から、第1部材1と第2部材2がスライドした距離、当該距離から、輪状体100の拡径の量を把握することができる。マーカー7は、X線を完全に遮断するものでなくてもよく、X線透視下においてマーカーの存在が検知できる程度のX線透過率であればよい。 3 and 4, it is preferable that a radiopaque marker 7 is formed on the first member 1 and the second member 2. When the medical tubular body enters the body, the degree of diameter expansion of the annular body 100 cannot be quantitatively confirmed. Therefore, by forming a radiopaque marker 7 at a predetermined position of the first member 1 and the second member 2, the first member 1 and the second member 2 can be obtained from the relative positional relationship of the markers 7. The amount of diameter expansion of the ring-shaped body 100 can be grasped from the distance that the member 2 has slid and the distance. The marker 7 does not need to completely block X-rays, and may be any X-ray transmittance that can detect the presence of the marker under fluoroscopy.
 図5は、図4の輪状体の第1部材1と第2部材2をB方向から見た斜視図である。図5に示されるように、第1部材1にはストッパー部8が形成され、第2部材2にはストッパー部9が形成されていることが好ましい。第1部材1と第2部材2とが互いにスライドして行き、最終的に第1部材1が第2部材2から抜けてしまうのではなく、第1部材1のストッパー部8と第2部材2のストッパー部9とが互いに当接した時点で、第1部材1と第2部材2とのスライドが完了する。すなわち、輪状体100の拡径が止まる。ストッパー部8は、第1部材1とは別の部材として形成されているものであってもよいし、第1部材1に一体形成されているものであってもよい。ストッパー部9についても同様であり、第2部材2とは別の部材として形成されているものであってもよいし、第2部材2に一体形成されているものであってもよい。 FIG. 5 is a perspective view of the first member 1 and the second member 2 of the ring-shaped body of FIG. 4 viewed from the B direction. As shown in FIG. 5, it is preferable that a stopper portion 8 is formed on the first member 1 and a stopper portion 9 is formed on the second member 2. The first member 1 and the second member 2 slide with each other, and the first member 1 does not eventually come out of the second member 2, but the stopper portion 8 of the first member 1 and the second member 2. When the stopper portions 9 come into contact with each other, the sliding of the first member 1 and the second member 2 is completed. That is, the diameter expansion of the ring-shaped body 100 stops. The stopper portion 8 may be formed as a member different from the first member 1 or may be integrally formed with the first member 1. The same applies to the stopper portion 9, and it may be formed as a member different from the second member 2, or may be integrally formed with the second member 2.
 図6は、本発明の実施の形態1にかかる医療用管状体の斜視図である。図6に示されるように、本実施の形態にかかる医療用管状体は、輪状体100を軸方向に複数有している。輪状体100が複数形成されていることにより、生体内管腔の病変部の特徴に応じて輪状体100毎に異なる拡径量を設定することも可能となるからである。これを実現するために、医療用管状体を拡径させるのに用いるバルーンを容量の異なる複数の袋状物によって構成することもできる。 FIG. 6 is a perspective view of the medical tubular body according to the first embodiment of the present invention. As shown in FIG. 6, the medical tubular body according to the present embodiment has a plurality of annular bodies 100 in the axial direction. This is because by forming a plurality of annular bodies 100, it is possible to set different diameter expansion amounts for each annular body 100 in accordance with the characteristics of the lesioned part of the lumen in the living body. In order to realize this, the balloon used for expanding the diameter of the medical tubular body can be constituted by a plurality of bag-like objects having different capacities.
 各輪状体100は、全て同じ物(同じ質量のもの)を用いてもよいが、輪状体100が生分解性物質を含む場合、各輪状体100が互いに異なる質量を有していてもよい。各輪状体100が全て同じ質量を有している場合、各輪状体100が完全に分解する時期がほぼ同時期となり、医療用管状体の形状が一気に崩れることが想定され、場合によっては、患者の生体内管腔の治療に影響を及ぼす可能性がある。各輪状体100が互いに異なる質量を有している場合、例えば、一つの輪状体100に含まれる第1部材1と第2部材2と、他の一つの輪状体100に含まれる第1部材1と第2部材2の太さが互いに異なる場合、輪状体100が生分解により崩れる時期を分散させることができ、生体内管腔の治療に及ぼす影響を小さくすることができる。 Each ring-shaped body 100 may be the same (same mass), but when the ring-shaped body 100 contains a biodegradable substance, each ring-shaped body 100 may have a different mass. When each ring-shaped body 100 has the same mass, it is assumed that the time when each ring-shaped body 100 is completely disassembled is almost the same period, and the shape of the medical tubular body collapses at once. May affect the treatment of in vivo lumens. When each ring-shaped body 100 has a different mass, for example, the first member 1 and the second member 2 included in one ring-shaped body 100 and the first member 1 included in another ring-shaped body 100 are included. When the thickness of the second member 2 is different from that of the second member 2, it is possible to disperse the time when the ring-shaped body 100 collapses due to biodegradation, and to reduce the influence on the treatment of the in vivo lumen.
 図6に示されるように、隣り合う輪状体100は、支柱10を介して互いに接続されることが好ましい。支柱10は、図6に示されるように第1部材1と第2部材2との間に接続されるものであってもよいし、第1部材1どうし、或いは第2部材2どうしの間に接続されるものであってもよい。 As shown in FIG. 6, it is preferable that the adjacent ring-shaped bodies 100 are connected to each other via the column 10. As shown in FIG. 6, the support column 10 may be connected between the first member 1 and the second member 2, or between the first members 1 or between the second members 2. It may be connected.
 図6に示されるように、医療用管状体はX線不透過性のマーカー11を有していることが望ましい。医療用管状体の体内における位置をX線透視下で把握するためである。当該マーカー11を支柱10の内側(輪状体100の径方向内方)に設けることにより、マーカー11が輪状体100の外方に突出しないため、生体内管腔内壁への刺激を低減することができる。また、少なくとも2つのマーカー11が、輪状体100の縮径時における軸方向の位置が互いに異なるように設計することにより、輪状体100の縮径時においてマーカー11どうしが互いに干渉しないため、輪状体100をより小さく縮径することができる。2つのマーカー11を輪状体の軸方向の異なる位置に形成させるための具体的態様は様々存在するが、図6に示すように支柱10の長さを異ならせる方法がある。 As shown in FIG. 6, the medical tubular body desirably has a radiopaque marker 11. This is for grasping the position of the medical tubular body in the body under fluoroscopy. By providing the marker 11 inside the support column 10 (inward in the radial direction of the ring-shaped body 100), the marker 11 does not protrude outward from the ring-shaped body 100, so that stimulation to the inner wall of the body lumen can be reduced. it can. Further, by designing the at least two markers 11 so that the positions in the axial direction when the diameter of the ring-shaped body 100 is reduced are different from each other, the markers 11 do not interfere with each other when the diameter of the ring-shaped body 100 is reduced. 100 can be reduced in diameter. Although there are various specific modes for forming the two markers 11 at different positions in the axial direction of the ring-shaped body, there is a method of varying the length of the column 10 as shown in FIG.
 輪状体100の構成要素である第1部材1や第2部材2の作製方法としては、射出成型法、レーザー加工法、機械的な切削加工、エッチング、3次元プリントなどを好適に用いることができる。 As a manufacturing method of the first member 1 and the second member 2 which are constituent elements of the ring-shaped body 100, an injection molding method, a laser processing method, a mechanical cutting process, etching, three-dimensional printing, and the like can be suitably used. .
 マーカー7、マーカー11を構成する材料としては、輪状体100の構成材料よりも高いX線不透過性を有する材料であれば特に限定されない。生体への影響を考慮すると、金属材料であることが好ましく、特に人体に対して良好な生物学的適合性に優れている点で、白金、パラジウム、タンタルであることが好ましい。特に、マーカーハウジングの材料としてニッケル-チタン合金が用いられている場合は、電気化学的電位の差が小さく、腐食しにくい点でタンタルであることが好ましい。 The material constituting the marker 7 and the marker 11 is not particularly limited as long as the material has higher radiopacity than the constituent material of the annular body 100. In consideration of the influence on the living body, a metal material is preferable, and platinum, palladium, and tantalum are preferable in view of excellent biocompatibility particularly with respect to the human body. In particular, when a nickel-titanium alloy is used as the material of the marker housing, tantalum is preferred because it has a small difference in electrochemical potential and is difficult to corrode.
 医療用管状体の大きさは特に限定されないが、実施の形態1において、管状体の外径は、縮経時に例えば0.36~0.46mm、拡径時に例えば4.0~4.5mm程度である。 The size of the medical tubular body is not particularly limited. In the first embodiment, the outer diameter of the tubular body is, for example, about 0.36 to 0.46 mm when contracted, and about 4.0 to 4.5 mm when expanding, for example. It is.
(実施の形態2)
 以下、本発明の実施の形態2にかかる医療用管状体について図面を用いて説明する。図7は、本発明の実施の形態2にかかる医療用管状体の展開図である。本発明の実施の形態2にかかる医療用管状体において、本発明の実施の形態1にかかる医療用管状体と同じ部材には同じ符号を付してその説明を省略する。
(Embodiment 2)
Hereinafter, the medical tubular body according to the second embodiment of the present invention will be described with reference to the drawings. FIG. 7 is a development view of the medical tubular body according to the second embodiment of the present invention. In the medical tubular body according to the second embodiment of the present invention, the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
 本発明の実施の形態2にかかる医療用管状体の輪状体100は、実施の形態1にかかるものとは異なり蛇行している。図7に示すように蛇行の幅(輪状体100の軸方向の長さ)をWとする。実施の形態2にかかる医療用管状体においては輪状体100が蛇行しているため、輪状体100の内側に配置されたバルーンが拡張することにより幅Wが減少しつつ輪状体100は拡径される。すなわち、実施の形態2にかかる医療用管状体の輪状体100は、(1)実施の形態1の輪状体100と同様に第1部材1と第2部材2とが互いにスライドすることによる拡径と、(2)上述のように輪状体100の蛇行の幅Wが減少することによる拡径の2種類の拡径機構を有している。このように、2種類の拡径機構を有することにより、拡径可能な倍率(最大径/最小径)を高めることができる。拡径可能な倍率を高めない場合であっても、蛇行を有する機構により輪状体100の拡径能力が高まるため、第1部材1と第2部材2の設計自由度が高まる。 Unlike the one according to the first embodiment, the annular body 100 of the medical tubular body according to the second embodiment of the present invention meanders. As shown in FIG. 7, the width of the meander (the axial length of the ring-shaped body 100) is W. In the medical tubular body according to the second embodiment, since the annular body 100 meanders, the balloon 100 disposed inside the annular body 100 expands to reduce the width W while the width W is reduced. The That is, the ring-shaped body 100 of the medical tubular body according to the second embodiment is (1) the diameter expansion due to the first member 1 and the second member 2 sliding relative to each other, like the ring-shaped body 100 of the first embodiment. (2) As described above, there are two types of diameter expansion mechanisms for expanding the diameter by reducing the meandering width W of the ring-shaped body 100. Thus, by having two types of diameter expansion mechanisms, the magnification (maximum diameter / minimum diameter) capable of diameter expansion can be increased. Even when the magnification capable of expanding the diameter is not increased, the diameter-enlarging ability of the ring-shaped body 100 is increased by the mechanism having meandering, so that the design freedom of the first member 1 and the second member 2 is increased.
 輪状体100を蛇行形状とするためには、例えば、図7に示すように、第1部材1および/または第2部材2とを、屈曲形状を有する第4部材12に接続する方法がある。これにより、第1部材1および/または第2部材2が直線的な形状の部材であっても、輪状体100を蛇行形状とすることができる。第4部材12は、塑性材料であることが望ましい。バルーン等により輪状体100を拡径した後、バルーン等を取り外しても輪状体100が拡径状態を維持するためである。他方、自己拡張型の医療用管状体を用いる場合は、第4部材12には弾性材料を用いることが望ましい。弾性材料であるほうが、医療用管状体の形状保持性が高いからである。 In order to make the ring-shaped body 100 meander, for example, as shown in FIG. 7, there is a method of connecting the first member 1 and / or the second member 2 to a fourth member 12 having a bent shape. Thereby, even if the 1st member 1 and / or the 2nd member 2 are members of a linear shape, the ring-shaped body 100 can be made to meander shape. The fourth member 12 is preferably a plastic material. This is because the ring-shaped body 100 maintains the expanded diameter state even if the balloon or the like is removed after the diameter of the ring-shaped body 100 is increased by a balloon or the like. On the other hand, when a self-expanding medical tubular body is used, it is desirable to use an elastic material for the fourth member 12. This is because the elastic material has higher shape retention of the medical tubular body.
 実施の形態2において、輪状体100が蛇行している状態においては、輪状体100の内側から外側に向かう応力を負荷しても、第1部材1と第2部材2は、周方向に互いにスライドしない程度のスライド抗力を有していることが望ましい。すなわち輪状体100が蛇行している状態においては、輪状体100の径方向の内方から外方に向かう応力を輪状体100に負荷すれば、蛇行幅Wが減少することにより輪状体100の周長が増加して輪状体100は更に拡径する余地があり、そのような状況の応力よりも、第1部材1と第2部材2のスライドに対する抗力を高く設定することを意味している。最終的に輪状体100の蛇行がなくなるまで輪状体100が伸び切れば、蛇行幅Wが減少することによる拡径は働かなくなるため、バルーン等により輪状体100の径方向内方から外方に向かって更に大きな応力を負荷すれば、実施の形態1の輪状体100と同様に第1部材1と第2部材2とが互いにスライドし始め、これによって輪状体100が更に拡径される。 In the second embodiment, when the ring-shaped body 100 is meandering, the first member 1 and the second member 2 slide in the circumferential direction even when stress is applied from the inside to the outside of the ring-shaped body 100. It is desirable to have a sliding drag that does not occur. In other words, in a state where the ring-shaped body 100 is meandering, if a stress is applied to the ring-shaped body 100 from the inner side to the outer side in the radial direction of the ring-shaped body 100, the meandering width W is reduced, thereby reducing the circumference of the ring-shaped body 100. As the length increases, the ring-shaped body 100 has room to further expand its diameter, which means that the resistance of the first member 1 and the second member 2 to the slide is set higher than the stress in such a situation. If the ring-shaped body 100 is fully extended until the ring-shaped body 100 finally disappears, the diameter expansion due to the decrease in the meandering width W does not work, so the balloon 100 or the like moves from the radially inner side to the outer side. If a greater stress is applied, the first member 1 and the second member 2 begin to slide with each other in the same manner as the ring-shaped body 100 of the first embodiment, and the ring-shaped body 100 is further expanded in diameter.
 このように、輪状体100が蛇行している状態においては輪状体100の径方向内方から外方に向かう応力を負荷しても第1部材1と第2部材2は周方向に互いにスライドしない程度のスライド抗力を有しているという構成は、第1部材1と第2部材2とがラチェット機構或いはスライドアンドロック機構を有する場合など、輪状体100の周長が増加する方向には互いにスライド可能であり輪状体100の周長が減少する方向には互いにスライドしない構成を有する場合に特に効果がある。すなわち、第1部材1と第2部材2のスライド量が元には戻らない構成であることにより、輪状体100の拡径の量を細かく制御することができる。輪状体100は、拡径の前期段階においては蛇行幅Wを減少させることにより拡径され、拡径の後期段階においては第1部材1と第2部材2が互いにスライドすることによる調整的な拡径がなされる。 Thus, in the state where the ring-shaped body 100 is meandering, the first member 1 and the second member 2 do not slide in the circumferential direction even when a stress is applied from the radially inner side to the outer side of the ring-shaped body 100. The structure of having a certain level of sliding drag is that the first member 1 and the second member 2 slide relative to each other in the direction in which the circumference of the ring-shaped body 100 increases, such as when the first member 1 and the second member 2 have a ratchet mechanism or a slide and lock mechanism. This is particularly effective when it has a configuration that does not slide in the direction in which the circumference of the ring-shaped body 100 decreases. That is, since the sliding amount of the first member 1 and the second member 2 is not restored, the amount of diameter expansion of the ring-shaped body 100 can be finely controlled. The ring-shaped body 100 is expanded in diameter by reducing the meandering width W in the first stage of diameter expansion, and is adjusted and expanded by sliding the first member 1 and the second member 2 in the second stage of diameter expansion. A diameter is made.
 これとは逆に、第1部材1と第2部材2との間のスライド抗力を低く設定することにより、拡径の前期段階においては第1部材1と第2部材2が互いにスライドすることによる拡径を行い、拡径の後期段階においては蛇行幅Wを減少させることにより拡径を行う構成とすることも可能である。この場合、蛇行幅Wがゼロとなる前に拡径が終了する場合があるが、蛇行した輪状体100は、柔軟性に富むため、生体内管腔の動きに追従しやすいというメリットがある。 On the contrary, by setting the sliding drag between the first member 1 and the second member 2 low, the first member 1 and the second member 2 slide on each other in the first stage of diameter expansion. It is possible to increase the diameter by increasing the diameter and decreasing the meandering width W in a later stage of the expansion. In this case, the diameter expansion may end before the meandering width W becomes zero. However, the meandering ring-shaped body 100 has a merit that it can easily follow the movement of the lumen in the living body because of its high flexibility.
 本明細書において「輪状体が蛇行している状態においては、輪状体の内側から外側に向かう応力を負荷しても、第1部材と第2部材は、周方向に互いにスライドしない程度のスライド抗力を有している」という規定の中の「輪状体が蛇行している状態」とは、輪状体の蛇行幅W(最大幅)が輪状体の最大直径Rの1/10よりも大きい状態を意味するものとする。また、「スライド抗力」とは、第1部材1と第2部材2とが、静止状態から、相対的なスライドをし始めるまでに要する力の大きさであり、例えば図2のラチェット機構の場合であれば、凸部3や凹部4の形状や数、剛性等により決まるものである。 In this specification, “in the state where the ring-shaped body is meandering, even if a stress is applied from the inside to the outside of the ring-shaped body, the first member and the second member do not slide each other in the circumferential direction. "The state in which the ring-shaped body is meandering" in the definition of "having a ring" means a state in which the meandering width W (maximum width) of the ring-shaped body is larger than 1/10 of the maximum diameter R of the ring-shaped body. Shall mean. The “sliding drag” is the magnitude of the force required for the first member 1 and the second member 2 to start relative sliding from a stationary state. For example, in the case of the ratchet mechanism of FIG. If so, it is determined by the shape, number, rigidity, and the like of the convex portions 3 and the concave portions 4.
(実施の形態3)
 以下、本発明の実施の形態3にかかる医療用管状体について図面を用いて説明する。図8は、本発明の実施の形態3にかかる医療用管状体の展開図である。本発明の実施の形態3にかかる医療用管状体において、本発明の実施の形態1にかかる医療用管状体と同じ部材には同じ符号を付してその説明を省略する。
(Embodiment 3)
Hereinafter, the medical tubular body according to the third embodiment of the present invention will be described with reference to the drawings. FIG. 8 is a development view of the medical tubular body according to the third embodiment of the present invention. In the medical tubular body according to the third embodiment of the present invention, the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
 本発明の実施の形態3にかかる医療用管状体の輪状体100は、実施の形態1にかかるものとは異なり、輪状体の軸方向における、第1部材1の幅と第2部材2の幅は、互いに異なるものである。例えば、図8に示されるように、第2部材2は、第1部材1よりも広い幅を有している。輪状体100が、幅の広い部材から構成されている場合は、血管等の屈曲や蛇行に対する追従性は相対的に落ちるものの、第2部材2が幅広い分、血管等の内壁への接触面積が大きく、刺激を少なくすることができる。したがって、血管等が再狭窄する確率が低減される。 Unlike the one according to the first embodiment, the ring-shaped body 100 of the medical tubular body according to the third embodiment of the present invention has the width of the first member 1 and the width of the second member 2 in the axial direction of the ring-shaped body. Are different from each other. For example, as shown in FIG. 8, the second member 2 has a wider width than the first member 1. When the ring-shaped body 100 is composed of a wide member, the followability to bending and meandering of the blood vessel and the like is relatively lowered, but the contact area to the inner wall of the blood vessel and the like is widened because the second member 2 is wide. Large and less irritating. Therefore, the probability that the blood vessel or the like is restenosis is reduced.
(実施の形態4)
 以下、本発明の実施の形態4にかかる医療用管状体について図面を用いて説明する。図9は、本発明の実施の形態4にかかる医療用管状体の展開図である。本発明の実施の形態4にかかる医療用管状体において、本発明の実施の形態1にかかる医療用管状体と同じ部材には同じ符号を付してその説明を省略する。
(Embodiment 4)
Hereinafter, the medical tubular body according to the fourth embodiment of the present invention will be described with reference to the drawings. FIG. 9 is a development view of the medical tubular body according to the fourth embodiment of the present invention. In the medical tubular body according to the fourth embodiment of the present invention, the same members as those in the medical tubular body according to the first embodiment of the present invention are denoted by the same reference numerals, and description thereof is omitted.
 上記実施の形態1にかかる医療用管状体の輪状体100では、第1部材1と第2部材2とは互いに軸方向に隣接しているのに対して、本実施の形態4にかかる医療用管状体の輪状体100では、第1部材1は第2部材2よりも内側に配されている。このように、一方の部材よりも内側に他方の部材を形成することにより、互いに逆方向にスライドする2つの部材(第1部材1と第2部材2)の境界部分が血管等の内壁に当接することを避けることができる。したがって、血管等が再狭窄する確率が低減される。もちろん、第2部材2が第1部材1よりも内側に配される構成であっても同様に実施し得る。 In the annular body 100 of the medical tubular body according to the first embodiment, the first member 1 and the second member 2 are adjacent to each other in the axial direction, whereas the medical member according to the fourth embodiment. In the tubular ring-shaped body 100, the first member 1 is arranged on the inner side than the second member 2. In this way, by forming the other member inside the one member, the boundary portion between the two members (first member 1 and second member 2) that slide in opposite directions from each other hits the inner wall of a blood vessel or the like. You can avoid touching. Therefore, the probability that the blood vessel or the like is restenosis is reduced. Of course, even if it is the structure where the 2nd member 2 is distribute | arranged inside the 1st member 1, it can implement similarly.
 本願は、2015年4月17日に出願された日本国特許出願第2015-85156号に基づく優先権の利益を主張するものである。2015年4月17日に出願された日本国特許出願第2015-85156号の明細書の全内容が、本願に参考のため援用される。 This application claims the benefit of priority based on Japanese Patent Application No. 2015-85156 filed on April 17, 2015. The entire contents of the specification of Japanese Patent Application No. 2015-85156 filed on April 17, 2015 are incorporated herein by reference.
1 第1部材
1a 上段
1b 下段
2 第2部材
2a 上段
2b 下段
3 凸部
4 凹部
5 溝
6 ガイド部
7 マーカー
8 ストッパー部
9 ストッパー部
10 支柱
11 マーカー
12 第4部材
100 輪状体
DESCRIPTION OF SYMBOLS 1 1st member 1a Upper stage 1b Lower stage 2 2nd member 2a Upper stage 2b Lower stage 3 Convex part 4 Concave part 5 Groove 6 Guide part 7 Marker 8 Stopper part 9 Stopper part 10 Strut 11 Marker 12 Fourth member 100 Ring-shaped body

Claims (15)

  1.  拡径可能な輪状体を有する医療用管状体であって、
     前記輪状体は、周方向と軸方向を有し、周方向の一部区間に形成されている第1部材と、周方向の一部区間に形成されている第2部材とを有しており、前記第1部材と前記第2部材とが互いに周方向にスライド可能に係合していることを特徴とする医療用管状体。
    A medical tubular body having a ring-shaped body capable of expanding the diameter,
    The annular body has a circumferential direction and an axial direction, and has a first member formed in a partial section in the circumferential direction and a second member formed in a partial section in the circumferential direction. The medical tubular body, wherein the first member and the second member are slidably engaged with each other in the circumferential direction.
  2.  前記第1部材と前記第2部材とは、前記輪状体の周長が増加する方向には互いにスライド可能であり、前記輪状体の周長が減少する方向には互いにスライドしない請求項1に記載の医療用管状体。 The said 1st member and the said 2nd member are mutually slidable in the direction where the circumferential length of the said annular body increases, and do not slide mutually in the direction where the circumferential length of the said annular body decreases. The medical tubular body.
  3.  前記第1部材には、前記第2部材に対向する面に、凸部が形成されており、
     前記第2部材には、前記第1部材に対向する面に、凹部が形成されており、
     前記凸部または前記凹部の少なくとも一方は、周方向に異方形状を有する請求項2に記載の医療用管状体。
    The first member has a convex portion formed on a surface facing the second member,
    The second member has a recess formed on the surface facing the first member,
    The medical tubular body according to claim 2, wherein at least one of the convex portion or the concave portion has an anisotropic shape in a circumferential direction.
  4.  前記第1部材および前記第2部材に、X線不透過性のマーカーが形成されている請求項1~3のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 3, wherein a radiopaque marker is formed on the first member and the second member.
  5.  前記第1部材および前記第2部材は、それぞれ、互いに当接し合うストッパー部を含む請求項1~4のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 4, wherein each of the first member and the second member includes a stopper portion in contact with each other.
  6.  複数の前記輪状体を有している請求項1~5のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 5, which has a plurality of the annular bodies.
  7.  前記複数の輪状体は、互いに異なる質量を有している請求項6に記載の医療用管状体。 The medical tubular body according to claim 6, wherein the plurality of annular bodies have different masses.
  8.  前記複数の輪状体どうしが支柱を介して接続されている請求項6または7に記載の医療用管状体。 The medical tubular body according to claim 6 or 7, wherein the plurality of ring-shaped bodies are connected to each other through a support column.
  9.  前記支柱が複数存在しており、各支柱にはX線不透過性のマーカーが配されており、各マーカーの軸方向の位置は互いに異なっている請求項8に記載の医療用管状体。 The medical tubular body according to claim 8, wherein a plurality of the support columns exist, and each support column is provided with a radiopaque marker, and the positions of the markers in the axial direction are different from each other.
  10.  前記輪状体は蛇行しており、蛇行の幅は、前記輪状体の拡径に伴い減少する請求項1~9のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 9, wherein the annular body is meandering, and the width of the meandering decreases as the diameter of the annular body increases.
  11.  前記輪状体が蛇行している状態においては、前記輪状体の径方向の内方から外方に向かう応力を負荷しても、前記第1部材と前記第2部材は、周方向に互いにスライドしない程度のスライド抗力を有している請求項10に記載の医療用管状体。 In a state where the ring-shaped body is meandering, the first member and the second member do not slide in the circumferential direction even when a stress is applied from the inside to the outside in the radial direction of the ring-shaped body. The medical tubular body according to claim 10, which has a degree of sliding drag.
  12.  前記輪状体の軸方向における、前記第1部材の幅と前記第2部材の幅は、互いに異なるものである請求項1~11のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 11, wherein a width of the first member and a width of the second member in the axial direction of the annular body are different from each other.
  13.  前記第1部材と前記第2部材とは互いに軸方向に隣接している請求項1~12のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 12, wherein the first member and the second member are adjacent to each other in the axial direction.
  14.  前記第1部材および前記第2部材は、一方よりも他方が前記輪状体の径方向の内方に配されている請求項1~13のいずれかに記載の医療用管状体。 The medical tubular body according to any one of claims 1 to 13, wherein the first member and the second member are disposed more radially inward than the other in the radial direction of the annular body.
  15.  前記輪状体が生分解性物質を含む請求項1~14のいずれかに記載の医療用管状体。
     
    The medical tubular body according to any one of claims 1 to 14, wherein the annular body contains a biodegradable substance.
PCT/JP2016/051924 2015-04-17 2016-01-22 Medical tubular body WO2016167002A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017512209A JPWO2016167002A1 (en) 2015-04-17 2016-01-22 Medical tubular body

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-085156 2015-04-17
JP2015085156 2015-04-17

Publications (1)

Publication Number Publication Date
WO2016167002A1 true WO2016167002A1 (en) 2016-10-20

Family

ID=57126158

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/051924 WO2016167002A1 (en) 2015-04-17 2016-01-22 Medical tubular body

Country Status (2)

Country Link
JP (1) JPWO2016167002A1 (en)
WO (1) WO2016167002A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108186174A (en) * 2017-12-30 2018-06-22 北京工业大学 Can uniform expansion high support stiffness biodegradable stent structure
CN111345925A (en) * 2020-02-27 2020-06-30 江苏理工学院 Novel blood vessel support
CN113367837A (en) * 2021-05-18 2021-09-10 罗文达 General aorta bracket for medical treatment
JP2021526916A (en) * 2018-06-11 2021-10-11 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated In vivo regulation mechanism, and related systems and methods

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549662A (en) * 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US20020138138A1 (en) * 2001-03-23 2002-09-26 Jibin Yang Rolled minimally-invasive heart valves and methods of use
JP2009502428A (en) * 2005-08-02 2009-01-29 レヴァ メディカル、 インコーポレイテッド Axial nested slide lock expandable device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549662A (en) * 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
US20020138138A1 (en) * 2001-03-23 2002-09-26 Jibin Yang Rolled minimally-invasive heart valves and methods of use
JP2009502428A (en) * 2005-08-02 2009-01-29 レヴァ メディカル、 インコーポレイテッド Axial nested slide lock expandable device

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108186174A (en) * 2017-12-30 2018-06-22 北京工业大学 Can uniform expansion high support stiffness biodegradable stent structure
JP2021526916A (en) * 2018-06-11 2021-10-11 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated In vivo regulation mechanism, and related systems and methods
JP7100718B2 (en) 2018-06-11 2022-07-13 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド In vivo regulation mechanism and related systems
US11806261B2 (en) 2018-06-11 2023-11-07 W. L. Gore & Associates, Inc. In vivo adjustment mechanism and associated systems and methods
CN111345925A (en) * 2020-02-27 2020-06-30 江苏理工学院 Novel blood vessel support
CN111345925B (en) * 2020-02-27 2022-03-25 江苏理工学院 Blood vessel support
CN113367837A (en) * 2021-05-18 2021-09-10 罗文达 General aorta bracket for medical treatment

Also Published As

Publication number Publication date
JPWO2016167002A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
JP6764960B2 (en) Stents and Catheter Stent Systems
JP6546761B2 (en) Stent
WO2016167002A1 (en) Medical tubular body
JP6736627B2 (en) Medical tubular body
EP2497448A1 (en) Stent delivery system
JP6120373B2 (en) Stent and stent delivery system
WO2018016259A1 (en) Stent
WO2014171183A1 (en) Medical tubular body
JP2008000193A (en) Self-expanding stent
JP5401148B2 (en) In vivo indwelling stent and biological organ dilator
JP6155765B2 (en) Gastrointestinal stent
US10722389B2 (en) Endoluminal stent
JP7029578B1 (en) Stent
JP2018068666A (en) Stent
WO2017130803A1 (en) Stent
JP5248165B2 (en) In vivo indwelling stent and biological organ dilator
EP3359064A1 (en) Thrombectomy device
JP2017148403A (en) Digestive tract stent
JP5064282B2 (en) In vivo indwelling stent and biological organ dilator
JPWO2014162384A1 (en) Stent
JP2018027104A (en) Stent
WO2018047519A1 (en) Stent
JP2011067282A (en) Device for improving affected region of biological organ
JP2009240612A (en) In-vivo indwelling stent and living organ dilator
CA2883013A1 (en) Highly flexible stent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16779794

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017512209

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16779794

Country of ref document: EP

Kind code of ref document: A1